Sat.Jan 04, 2025 - Fri.Jan 10, 2025

article thumbnail

PBMs have evaded lawmakers’ reform attempts so far. Could 2025 turn the tide?

PharmaVoice

How regulators could hit PBMs from multiple sides in the coming year.

130
130
article thumbnail

Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagship’s Valo Health

MedCity News

Novo Nordisk and Valo Health have collaborated on the development of cardiovascular disease drugs since 2023. Expanding the alliance to cardiometabolic diseases nearly doubles the number of programs covered under the agreement. The post Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagships Valo Health appeared first on MedCity News.

Biopharma 125
article thumbnail

Amgen’s lung cancer treatment gets conditional approval

PharmaTimes

IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer

Patients 127
article thumbnail

FDA issues first recommendations on AI for drug development

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has for the first time, issued draft guidance on using artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product. The guidelines address the safety, effectiveness or quality of these medicines. FDA has previously published a discussion paper that was produced to inform its guidance on AI in pharmaceutical drug development.

article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

FDA issues first guidance on AI in medicine development

pharmaphorum

The FDA has placed the credibility of AI's 'context of use' in pharma development at the heart of its first guidance in this area

FDA 116
article thumbnail

Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by €2.4B

MedCity News

Galapagos said the planned business separation will leave the legacy company free to focus on developing cell therapies for cancer. An accompanying corporate restructuring will shave Galapagoss headcount by 40%. The post Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by 2.4B appeared first on MedCity News.

Biopharma 116

More Trending

article thumbnail

After layoffs, a viral immunotherapy biotech bounced back with a late-stage prostate cancer win

PharmaVoice

Candel Therapeutics’ CEO had to prioritize a phase 3 program amid layoffs and cuts, and an end-of-year clinical success was the redemption he was looking for.

112
112
article thumbnail

MSD buys Irish vaccines plant from WuXi for €500m

pharmaphorum

MSD has expanded its presence in Ireland with an agreement to buy a vaccines manufacturing facility from WuXi Biologics in Dundalk.

article thumbnail

Over 300 Organizations Call on New Congress to Safeguard and Strengthen Medicaid

MedCity News

Families USA led a letter urging the new Congress, which was sworn in on Jan. 3, to protect Medicaid. The post Over 300 Organizations Call on New Congress to Safeguard and Strengthen Medicaid appeared first on MedCity News.

123
123
article thumbnail

Goals of the Association for Prescription Psychedelics

Pharmaceutical Commerce

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), provides a peek into what the association has set out to accomplish.

article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

3 trial readouts that could shake up the obesity market this year

PharmaVoice

A wave of new weight loss treatments is on the way, and drugmakers are scrambling for a foot in the door.

Marketing 111
article thumbnail

Novo Nordisk asks FDA not to allow GLP-1 compounding

pharmaphorum

Novo Nordisk has asked the FDA to block compounders from making versions of its older, once-daily GLP-1 agonist liraglutide.

FDA 111
article thumbnail

What AI Can Do for Pharmacist Burnout

MedCity News

AI offers a number of immediate opportunities for pharmacies to change their operation through intelligent automation, freeing up pharmacists to provide their patient population with higher-value services like patient counseling and medication management. The post What AI Can Do for Pharmacist Burnout appeared first on MedCity News.

article thumbnail

NICE recommends olaparib for BRCA-mutated breast cancer treatment

PharmaTimes

Groundbreaking approval provides new hope for patients in England and Wales

Patients 107
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

PharmaVoice’s Crystal Ball: Industry shifts in R&D, policy and clinical trials

PharmaVoice

Coming changes that could impact pharma from drug development to launch.

Pharma 99
article thumbnail

AMD shadows NVIDIA with a move into AI drug discovery

pharmaphorum

Chipmaker AMD has taken a 20% stake in Absci, a specialist in the use of artificial intelligence in for biologic drug discovery.

106
106
article thumbnail

Metabolic Meds Startup Verdiva Launches With $411M and a Weekly Oral GLP-1 Drug

MedCity News

Verdiva Bios once-a-week oral GLP-1 drug is ready for Phase 2 testing. The drug, made with a proprietary technology that enables oral dosing, was licensed from Sciwind Biosciences. The post Metabolic Meds Startup Verdiva Launches With $411M and a Weekly Oral GLP-1 Drug appeared first on MedCity News.

Biopharma 109
article thumbnail

New prostate cancer test cuts biopsies by 50% in US

PharmaTimes

EpiSwitch PSE shows promise in reducing unnecessary procedures

108
108
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Your Brain on Prompts: The Science of Smooth Sailing

ALULA

Outsmart your brain & achieve goals! Learn how to leverage your brain's neural network with powerful prompts. Environmental, digital, social, & emotional cues for lasting change.

article thumbnail

Verdiva Bio raises $411m for obesity pipeline

pharmaphorum

A new obesity start-up Verdiva Bio has just decloaked with a whopping $411m to advance a once-weekly oral GLP-1 agonist.

106
106
article thumbnail

Understanding the Ethics of AI in ABA Therapy

MedCity News

Certified clinicians and therapists have specific ethical foundations and analytic responsibilities to uphold that might not apply to all members of the healthcare field. The post Understanding the Ethics of AI in ABA Therapy appeared first on MedCity News.

Ethics 120
article thumbnail

Angelini Ventures co-leads Series A financing in Neumirna Therapeutics

PharmaTimes

Investment to support RNA therapeutics for epilepsy and neurological disorders

Leads 106
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Level Up Your Life: The Ultimate Prompt Strategy Guide

ALULA

Behavior-hack your way to success! Final installment. Learn the POWER Framework: Plan, Observe, Work, Evaluate, Repeat. Fun experiments to improve work & life.

97
article thumbnail

Ouro makes debut with $120m for autoimmune disease TCEs

pharmaphorum

Ouro launches today with $120m in funding and a plan to develop bispecific antibody-based T cell engagers for autoimmune diseases.

105
105
article thumbnail

Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More

MedCity News

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence technologies and the IPO markets return to normal levels. The post Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More appeared first on MedCity News.

Biopharma 122
article thumbnail

Novartis gene therapy set to enhance SMA treatment

PharmaTimes

OAV101 IT expands potential for type II SMA patients

Patients 101
article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

article thumbnail

Building a Voice for Psychedelic Research

Pharmaceutical Commerce

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), explains why this resource is an asset, specifically for research in the psychedelic space.

article thumbnail

EU pharma calls for speedy shift to digital package inserts

pharmaphorum

Pharma groups have called for EU adoption of electronic product information (ePI) to take place within four years in a new position paper.

Pharma 105
article thumbnail

Study: Why Quick Fixes Don’t Work in Workplace Wellness

MedCity News

By grounding wellness programs in behavior-change science, employers can empower their people to build healthier, more sustainable habits. The post Study: Why Quick Fixes Dont Work in Workplace Wellness appeared first on MedCity News.

Patients 117
article thumbnail

Merck unveils new cyber-physical trust platform at CES 2025

PharmaTimes

M-Trust set to improve product safety and counterfeiting solutions

Safety 98
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten